Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Press Release
King of Prussia, PA – May 3, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA: RBQM leader, CluePoints, has today announced that Amit Patel will join as...
- Press Release
King of Prussia, PA – March 23rd, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
Authors: Steve Young, Chief Scientific Officer Sylviane de Viron, Data and Knowledge Manager In the face...
- Press Release
King of Prussia, PA – 6 February 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper...
- Press Release
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is...
- Press Release
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the...
- Press Release
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful...
- Featured Article
Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review,...
Source: Contract Pharma
- Featured Article
As a follow-up to Clinical Trials Day 2025, held on May 20 with the theme of...
Source: The Association of Clinical Research Professionals
- Featured Article
“Identifying … potential data manipulation and data integrity problems” are an International Council for Harmonization of...
Source: Applied Clinical Trials
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Featured Article
Dr Laura Trotta gives us an insight into her role at CluePoints and shares some of...
Source: Health Tech World
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
